Abbott Launches SimpleScreen CRC Blood Test for Colorectal Cancer Screening
medical-exam

Abbott Launches SimpleScreen CRC Blood Test for Colorectal Cancer Screening

Colorectal cancer screening is getting another option for adults who may avoid stool tests or colonoscopy. Abbott has commercially launched SimpleScreen CRC in the United States, an FDA-approved blood test for colorectal cancer (CRC) screening in average-risk adults ages 45 and older. Freenome developed and manufactures the test, while Abbott distributes it exclusively in the […]

By Ami Ciccone · October 15, 2026
Read Now →